Werewolf Therapeutics, Inc.Werewolf Therapeutics, Inc.Werewolf Therapeutics, Inc.

Werewolf Therapeutics, Inc.

No trades
See on Supercharts

Price target

9.600.000.00%
The 5 analysts offering 1 year price forecasts for HOWL have a max estimate of — and a min estimate of —.

Analyst rating

Based on 5 analysts giving stock ratings to HOWL in the past 3 months.

EPS

Reported
Estimate
Reported
Estimate
Surprise

Revenue

Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions


HOWL EPS for the last quarter is −0.46 USD despite the estimation of −0.40 USD. In the next quarter EPS is expected to reach −0.39 USD. Track more of Werewolf Therapeutics, Inc. financials and stay on top of what is up with the company.
In the next quarter Werewolf Therapeutics, Inc. revenue is expected to reach 0.00 USD. Check out Werewolf Therapeutics, Inc. revenue and earnings and make informed decisions.
According to analysts, HOWL price target is 9.60 USD with a max estimate of 15.00 USD and a min estimate of 4.00 USD. Check if this forecast comes true in a year, meanwhile watch Werewolf Therapeutics, Inc. stock price chart and keep track of the current situation with HOWL news and stock market news.
We've gathered opinions of 5 analysts rating HOWL stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as strong buy. Note that it's not a trading advice — your own analysis is still required.